Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TCM Biotech International Corp. is a Taiwan-based biotechnology company specializing in the development and commercialization of molecular diagnostic kits and pharmaceutical products. The company focuses on infectious diseases and oncology, providing high-sensitivity diagnostic solutions for Hepatitis B, Hepatitis C, and HIV. In addition to its diagnostic portfolio, TCM Biotech is involved in the development of therapeutic agents and vaccines aimed at addressing significant unmet needs in liver disease and viral infections. The company operates with a mission to integrate advanced biotechnology into clinical practice to improve patient outcomes globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TCM.